<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04970017</url>
  </required_header>
  <id_info>
    <org_study_id>17200538</org_study_id>
    <nct_id>NCT04970017</nct_id>
  </id_info>
  <brief_title>Correlation Between Left Ventricular Global Strain Measured by Speckle Tracking Echocardiography and Scar Burden Measured by Cardiac Magnetic Resonance Imaging in Patients With Ischemic Heart Disease</brief_title>
  <official_title>Correlation Between Left Ventricular Global Strain Measured by Speckle Tracking Echocardiography and Scar Burden Measured by Cardiac Magnetic Resonance Imaging in Patients With Ischemic Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To verify whether GLS and LV mechanical dispersion, measured by two-dimensional&#xD;
      speckle-tracking echocardiography (2D-STE) correlate with LV scar burden measured by cardiac&#xD;
      MRI in patients with ischemic heart disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of presence, localization, and extent of left ventricular(LV) scar tissue in&#xD;
      patients with ischaemic heart disease (IHD) is of fundamental importance in clinical&#xD;
      practice. It affects the decision making regarding revascularization and is a determinant of&#xD;
      subsequent mortality. (Mele, Fiorencis et al. 2016) Late gadolinium contrast-enhanced cardiac&#xD;
      magnetic resonance (LGE-CMR) is considered the current gold standard technique for assessment&#xD;
      of the scar burden in IHD patients. However, it is not readily accessible in many areas due&#xD;
      to availability and cost issues.(Abou, Prihadi et al. 2020), (Bendary, Afifi et al. 2019)&#xD;
      Several recent studies suggested 2-D speckle tracking strain as a potential surrogate for&#xD;
      cardiovascular magnetic resonance (CMR) late gadolinium enhancement (LGE) imaging. This would&#xD;
      be useful in cases where CMR is not available, gadolinium contrast is contraindicated, or in&#xD;
      patients at greater risk of adverse long term events. (Erley, Genovese et al. 2019) Among&#xD;
      echocardiography derived strain measurements, global longitudinal strain (GLS) was shown to&#xD;
      be superior to global circumferential strain (GCS) in its ability to detect subtle myocardial&#xD;
      abnormalities due to better reproducibility (Erley et al, 2019). Left ventricular mechanical&#xD;
      dispersion (LVMD) is also considered a valuable parameter that was associated with outcomes&#xD;
      after myocardial infarction. (Abou, Prihadi et al. 2020).&#xD;
&#xD;
      Despite the growing number of strain related studies in the literature, it is not clear&#xD;
      whether the relationship of strain measurements with LGE is strong enough for strain to be&#xD;
      considered as a surrogate. (Erley, Genovese et al. 2019). Also, the differences between GLS&#xD;
      and LV MD among strain components in this context are not well established.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Scare burden by echocardiography</measure>
    <time_frame>One year</time_frame>
    <description>To test the correlation between the scar burden measured by cardiac MRI and GLS measured by 2D STE</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Value of spickle tracking echocardiography in clinical practice</measure>
    <time_frame>One year</time_frame>
    <description>Predicting the scar burden in ICMP patients by GLS and mechanical dispersion.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">51</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Cardiac MRI, Echocardiography</intervention_name>
    <description>Magnetic resonance imaging, Echocardiography</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting for viability assessment in to cardiac MRI unit, Assiut university&#xD;
        heart hospital, with a history of previous stemi, at least 3 months after the acute event (&#xD;
        scar stabilization) and up to one year&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  â€¢ Patients presenting for viability assessment in to cardiac MRI unit, Assiut&#xD;
             university heart hospital, with a history of previous stemi, at least 3 months after&#xD;
             the acute event ( scar stabilization) and up to one year&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with:&#xD;
&#xD;
               -  Contraindication to cardiac MRI (claustrophobia, Patients with eGFR below 30&#xD;
                  mL/min/1.73 m2. and patients with metallic implants)&#xD;
&#xD;
               -  Non-ischemic cardiomyopathy.&#xD;
&#xD;
               -  Valvular heart disease (VHD).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Mohamed Abdellatif</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed Abdellatif, MSC</last_name>
    <phone>+201001073747</phone>
    <email>mohamed.abdellatief@med.au.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shimaa Sayed Khidr, PHD</last_name>
    <phone>+201001346551</phone>
    <email>S.khidr@aun.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assiut university</name>
      <address>
        <city>Assiut</city>
        <zip>71511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Abdellatif</last_name>
      <phone>00201001073747</phone>
      <email>Mohamed.abdellatief@med.au.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>July 16, 2021</study_first_submitted>
  <study_first_submitted_qc>July 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 16, 2021</last_update_submitted>
  <last_update_submitted_qc>July 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohamed Mahmoud Mohamed Abdellatif</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

